動脈硬化 は 滑らかな 筋肉 の 細胞 に よっ て 発生 する 腫瘍 の よう な 病気 です
PubMedで要約を見る
まとめ
この要約は機械生成です。動脈硬化では,滑らかな筋肉細胞 (SMC) が腫瘍細胞のように振る舞い,ゲノム不安定性と過剰増殖を呈する. ニラパリブのような薬で SMCの移行をターゲットにすることで この心血管疾患の治療の可能性が示されています
科学分野
- 心血管生物学
- 癌 生物学
- 翻訳医学
背景
- 動脈硬化症は多種多様な細胞の 病的な活性化によって引き起こされる 心血管疾患の主な原因です
- 滑らかな筋肉細胞 (SMC) のフェノタイプスイッチングは,動脈硬化症の発達と合併症の重要な要因としてますます認識されています.
- SMCから派生した細胞の病気の病原性における正確な性質と根本的なメカニズムはよく理解されていません.
研究 の 目的
- 動脈硬化症におけるSMC由来細胞の腫瘍細胞のような振る舞いを特徴づける.
- 動脈硬化症の文脈でSMC移行を駆動するメカニズムを解明する.
- 動脈硬化症の予防と治療のためのSMC移行を標的とした新しい治療戦略を探求する.
主な方法
- マウスにおけるSMC系統の追跡とヒト組織の分析を活用した.
- 分子,細胞,組織学的,計算的,遺伝的方法を含む多分野アプローチを採用しました.
- 腫瘍性Kras発現の影響を調査し,抗癌薬ニラパリブの有効性を試験した.
主要な成果
- 動脈硬化におけるSMC由来細胞は,腫瘍細胞のような特徴:ゲノム不安定性,老化の回避,過剰増殖,侵襲性,および癌に関連した遺伝子ネットワークを示す.
- SMCにおける腫瘍性KrasG12Dの発現はSMCの移行を加速し,動脈硬化症を悪化させる.
- DNA 損傷修復阻害剤のニラパリブは,アテロスクレロスの進行を減らし,マウスモデルで病変の回復を誘導した.
結論
- 動脈硬化症はSMCによって引き起こされる 腫瘍のような病気であり 病原性に関する新しい洞察を 提供しています
- これらの発見は,SMC移行をターゲットとした革新的な精密分子戦略の道を開く.
- SMCの移行をターゲットにすることで,動脈硬化性心血管疾患の有望な治療法となる.
関連する概念動画
Smooth muscle tissue is a type of muscle tissue that can be found lining various vital organs in the human body, including the lungs, blood vessels, digestive tract, and respiratory tract. This type of tissue is responsible for regulating the movements of these organs, playing crucial roles in the functioning of various systems, including the vascular, digestive, respiratory, and urinary systems.
Structure of smooth muscle cell
Smooth muscle cells are spindle-shaped with tapering ends and a...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Overview
In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

